...
首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Easy-to-Read Informed Consent Form for Hematopoietic Cell Transplantation Clinical Trials: Results from the Blood and Marrow Transplant Clinical Trials Network 1205 Study
【24h】

Easy-to-Read Informed Consent Form for Hematopoietic Cell Transplantation Clinical Trials: Results from the Blood and Marrow Transplant Clinical Trials Network 1205 Study

机译:None

获取原文
获取原文并翻译 | 示例

摘要

Because of the complexity of hematopoietic cell transplant trial treatments, informed consent forms are often long and difficult to read. We evaluated a 2-column easy-to-read informed consent (ETRIC) form that incorporates elements of health literacy and readability in participants and centers participating in Blood and Marrow Transplant Clinical Trials Network (BMT CTN) clinical trials. In a randomized study 198 adult patients from 25 centers potentially eligible to participate in 4 BMT CTN interventional trials were randomized to the ETRIC form or a standard consent form for that trial. Both forms were written at no more than an eighth-grade reading level. The primary endpoint was objective comprehension score on the Quality of Informed Consent, part A (QuIC-A) instrument. In a parallel evaluation study, 2 moderators conducted semistructured interviews of 49 investigators, research staff, and institutional review board (IRB) members at 9 BMT CTN trial sites. The mean QuIC-A scores were comparable in 152 patients (77%) assessable for the primary endpoint (ETRIC form, 80.5; standard form, 81.8;P?=?.37). In regression analysis there was no significant association between the consent type and QuIC-A score. In the evaluation study dominant themes identified on qualitative analyses included general comfort and willingness to use the ETRIC template and that its formatting and layout enhancements would offer additional value to research participants, investigators, and IRBs. IRB language preferences and requirements, length, and prior experience with alternative consent formats were perceived as barriers. Among patients considering participation in BMT CTN clinical trials, the formatting enhancements of the ETRIC form did not alter comprehension of the trial. Despite local challenges to implementation, trial sites generally viewed the ETRIC form favorably and expressed willingness to use it over standard consent form.
机译:由于造血细胞移植审判治疗的复杂性,知情同意形式往往漫长而难以阅读。我们评估了一份2列易于阅读的知情同意(Etric)形式,该表格包含了参与者和参与血液和骨髓移植临床试验网络(BMT CTN)临床试验的患者和中心的能力的元素。在一项随机研究中,198年成年患者可能有资格参加4 BMT CTN介入试验的25个中心被随机转移到Etric表格或该试验的标准同意书。这两种形式都没有超过八级阅读水平。主要终点是客观理解得分对知情同意的质量,部分(Quic-a)仪器。在一个并行评估研究中,2个主持人在9 BMT CTN试验站点进行了49名调查员,研究人员和机构审查委员会(IRB)成员的晶体化访谈。平均Quic-A分数在152名患者(77%)可评估的主要终点(Etric形式,80.5;标准形式,81.8; p?= 37)。在回归分析中,同意类型与Quic-A分数之间没有重大关联。在评估研究中,在定性分析中确定的主导主题包括使用Etric模板的一般舒适性和意愿,其格式和布局增强将为研究参与者,调查人员和IRB提供额外的价值。具有替代同意格式的IRB语言偏好和要求,长度和事先经验被认为是障碍。在考虑参与BMT CTN临床试验的患者中,Etric形式的格式增强并未改变试验的理解。尽管实施了当地挑战,但审判网站普遍认为Etric表明愿意在标准同意书中使用它。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号